4.8 Article

The apoptotic signaling pathway activated by Toll-like receptor-2

Journal

EMBO JOURNAL
Volume 19, Issue 13, Pages 3325-3336

Publisher

WILEY
DOI: 10.1093/emboj/19.13.3325

Keywords

apoptosis; bacterial lipoprotein; MyD88; NF-kappa B; TLR2

Funding

  1. NIAID NIH HHS [AI 37720-04, R01 AI037720] Funding Source: Medline

Ask authors/readers for more resources

The innate immune system uses Toll family receptors to signal for the presence of microbes and initiate host defense. Bacterial lipoproteins (BLPs), which are expressed by all bacteria, are potent activators of Toll-like receptor-2 (TLR2). Here we show that the adaptor molecule, myeloid differentiation factor 88 (MyD88), mediates both apoptosis and nuclear factor-kappa B (NF-kappa B) activation by BLP-stimuiated TLR2, Inhibition of the NF-kappa B pathway downstream of MyD88 potentiates apoptosis, indicating that these two pathways bifurcate at the level of MyD88, TLR2 signals for apoptosis through MyD88 via a pathway involving Fas-associated death domain protein (FADD) and caspase 8, Moreover, MyD88 binds FADD and is sufficient to induce apoptosis, These data indicate that TLR2, is a novel 'death receptor' that engages the apoptotic machinery without a conventional cytoplasmic death domain. Through TLR2, BLP induces the synthesis of the precursor of the pro-inflammatory cytokine interleukin-1 beta (TL-1 beta). Interestingly, BLP also activates caspase 1 through TLR2, resulting in proteolysis and secretion of mature IL-1 beta, These results indicate that caspase activation is an innate immune response to microbial pathogens, culminating in apoptosis and cytokine production.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available